Skip to Main Content

Paper Details

Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance.
JAC Antimicrob Resist
2
2023

Datasets

Release 1.2